Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Adrenal Tumors Clinical Trial

Official title: Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.

Clinical Trial Description

Adrenal radiofrequency (RF) ablation has been increasingly used for the treatment of unresectable adrenal tumors. But one of the major complication is a increase in blood pressure. Hormonal release during RF ablation is considered the cause of hypertension. But there has been no evidence that adrenal hormones affects changes in blood pressure. In this prospective study, we evaluate the changes in adrenal hormones during RF ablation and clarify the cause of hypertensive crisis. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Adrenal Gland Neoplasms
• Adrenal Tumors

• NCT number: NCT00997594
• Study type: Interventional
• Source: Mie University
• Status: Completed
• Phase: Phase 2/Phase 3
• Start date: October 2009
• Completion date: October 2010